Nallalerumal Chidambaram

Suggest Changes
Learn More
PURPOSE To describe the Food and Drug Administration (FDA) review and approval of erlotinib (Tarceva, OSI Pharmaceuticals, Melville, NY) for treatment of patients with locally advanced or metastatic(More)